Benitec Biopharma Ltd ADR (BNTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Sales | 0 | 0 | 75 | 73 | 59 |
| Cost of Goods | N/A | -108 | N/A | 9 | 123 |
| Gross Profit | N/A | 108 | 75 | 64 | -64 |
| Operating Expenses | 41,765 | 22,490 | 19,156 | 17,927 | 13,655 |
| Operating Income | -41,765 | -22,490 | -19,081 | -17,854 | -13,596 |
| Interest Expense | 0 | 0 | 0 | 32 | 6 |
| Other Income | 3,848 | 739 | -481 | -322 | -280 |
| Pre-tax Income | -37,917 | -21,751 | -19,562 | -18,208 | -13,882 |
| Net Income Continuous | -37,917 | -21,751 | -19,562 | -18,208 | -13,882 |
| Net Income | $-37,917 | $-21,751 | $-19,562 | $-18,208 | $-13,882 |
| EPS Basic Total Ops | -1.05 | -1.22 | -14.12 | -37.88 | -54.93 |
| EPS Basic Continuous Ops | -1.05 | -1.18 | -14.11 | -37.88 | -54.97 |
| EPS Diluted Total Ops | -1.05 | -1.22 | -14.12 | -37.88 | -54.93 |
| EPS Diluted Continuous Ops | -1.05 | -1.18 | -14.11 | -37.88 | -54.97 |
| EPS Diluted Before Non-Recurring Items | -1.08 | -6.00 | -14.12 | -37.93 | -54.93 |
| EBITDA(a) | $-41,699 | $-22,403 | $-18,945 | $-17,687 | $-13,365 |